TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease - PubMed (original) (raw)

. 1993 Dec;23(12):3096-103.

doi: 10.1002/eji.1830231208.

Affiliations

• PMID: 8258322
• DOI: 10.1002/eji.1830231208

TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease

A Saoudi et al. Eur J Immunol. 1993 Dec.

Abstract

Mercuric chloride (HgCl2) injections protect (Lewis x Brown-Norway) F1 (F1) rats against experimental autoimmune uveoretinitis (EAU) induced by immunization with the retinal S antigen (S-Ag); in contrast HgCl2-injected F1 rats develop EAU following transfer of lymph node (LN) cells from rats immunized with S-Ag alone. In the present study we demonstrate that the ability of LN cells from rats protected against EAU to transfer the disease into naive F1 rats was considerably reduced. These LN cells neither produced interleukin (IL)-2 nor (interferon (IFN)-gamma but exhibited mRNA for IL-4. In contrast, LN cells from diseased rats easily transferred EAU into naive F1 rats, produced significant IL-2 and IFN-gamma levels but barely exhibited mRNA for IL-4. Furthermore protected rats predominantly produced IgG1 anti-S-Ag antibodies, while diseased rats produced IgG2b anti-S-Ag antibodies and the increase in expression of MHC class II molecules on B cells was higher in protected rats than in diseased rats. These data suggest that (1) to exert a protective effect, HgCl2 must act at an early stage of differentiation of precursors of S-Ag specific T cells, and (2) this effect is related to the preferential activation of TH2 cells to the detriment of uveitogenic TH1 cells. Finally, these results indicate that activation of TH2 cells protect from a TH1-dependent autoimmune disease.

PubMed Disclaimer

Similar articles

• Prevention of experimental autoimmune uveoretinitis and experimental autoimmune pinealitis in (Lewis x Brown-Norway) F1 rats by HgCl2 injections.
  Saoudi A, Bellon B, de Kozak Y, Kuhn J, Vial MC, Thillaye B, Druet P. Saoudi A, et al. Immunology. 1991 Oct;74(2):348-54. Immunology. 1991. PMID: 1748484 Free PMC article.
• Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats.
  Ramanathan S, de Kozak Y, Saoudi A, Goureau O, Van der Meide PH, Druet P, Bellon B. Ramanathan S, et al. J Immunol. 1996 Sep 1;157(5):2209-15. J Immunol. 1996. PMID: 8757348
• Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4.
  Prigent P, Saoudi A, Pannetier C, Graber P, Bonnefoy JY, Druet P, Hirsch F. Prigent P, et al. J Clin Invest. 1995 Sep;96(3):1484-9. doi: 10.1172/JCI118185. J Clin Invest. 1995. PMID: 7657819 Free PMC article.
• Th2 and Th1 autoreactive anti-class II cell lines in the rat suppress or induce autoimmunity.
  Druet P, Pelletier L. Druet P, et al. J Autoimmun. 1996 Apr;9(2):221-6. doi: 10.1006/jaut.1996.0027. J Autoimmun. 1996. PMID: 8738966 Review.
• Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control.
  Fournié GJ, Saoudi A, Druet P, Pelletier L. Fournié GJ, et al. Autoimmun Rev. 2002 Aug;1(4):205-12. doi: 10.1016/s1568-9972(02)00052-6. Autoimmun Rev. 2002. PMID: 12848997 Review.

Cited by

• Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells.
  Iwasaki A, Kelsall BL. Iwasaki A, et al. J Exp Med. 1999 Jul 19;190(2):229-39. doi: 10.1084/jem.190.2.229. J Exp Med. 1999. PMID: 10432286 Free PMC article.
• 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
  Ohtsuru I, Matsuo H, Fukudome T, Suenaga A, Tsujihata M, Nagataki S. Ohtsuru I, et al. Clin Exp Immunol. 1995 Dec;102(3):462-7. doi: 10.1111/j.1365-2249.1995.tb03838.x. Clin Exp Immunol. 1995. PMID: 8536358 Free PMC article.
• The role of cytokines in ocular inflammation.
  Kijlstra A. Kijlstra A. Br J Ophthalmol. 1994 Dec;78(12):885-6. doi: 10.1136/bjo.78.12.885. Br J Ophthalmol. 1994. PMID: 7819166 Free PMC article. No abstract available.
• Suppression of induction of experimental immune mediated blepharoconjunctivitis by tolerogenic conjugates of the antigen and monomethoxypolyethylene glycol.
  Fukushima A, Nishino K, Yoshida H, Takata M, Ueno H. Fukushima A, et al. Br J Ophthalmol. 1999 Aug;83(8):973-9. doi: 10.1136/bjo.83.8.973. Br J Ophthalmol. 1999. PMID: 10413705 Free PMC article.
• Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
  Smith TRF, Schultheis K, Morrow MP, Kraynyak KA, McCoy JR, Yim KC, Muthumani K, Humeau L, Weiner DB, Sardesai NY, Broderick KE. Smith TRF, et al. Vaccine. 2017 May 15;35(21):2840-2847. doi: 10.1016/j.vaccine.2017.04.008. Epub 2017 Apr 14. Vaccine. 2017. PMID: 28413132 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program